|
|
Diabetes News Archive
May 12, 2010, 23:03 GMT
People with diabetes have an increased risk of blindness, yet nearly half of the approximately 23 million Americans with diabetes do not get an annual eye exam to detect possible problems.
May 12, 2010, 21:33 GMT
( University of Iowa - Health Science ) People with diabetes have an increased risk of blindness, yet nearly half of the approximately 23 million Americans with diabetes do not get an annual eye exam to detect possible problems. But it appears that cost-effective computerized systems to detect early eye problems related to diabetes can help meet the screening need, University of Iowa analysis ...
May 12, 2010, 20:29 GMT
HUNTINGTON -- The Tri-State Diabetes Association will host a support group meeting at 7 p.m. Tuesday, May 18, at St. Mary's Regional Heart Institute, Room 205, 2900 1st Ave., Huntington.
May 12, 2010, 15:04 GMT
Sparta Sussex County will offer a new self-management program beginning on Tuesday, May 11, for those dealing with or at risk for diabetes,
May 12, 2010, 14:17 GMT
Treating serious gum disease in diabetics can help to lower their blood sugar levels, a study has shown.Researchers have found that reducing inflammation of the gums in people with diabetes can help lower the risk of serious complications associated with the condition, such as eye problems and heart disease.The study led by the University of Edinburgh analyzed the findings of previous ...
May 12, 2010, 13:30 GMT
When people with diabetes smoke cigarettes, the results can be deadly. Quitting smoking is crucial for good blood sugar control. Try these tips to kick the habit.
May 12, 2010, 10:07 GMT
We all have a role to play in the fight against obesity and diabetes, as well as other chronic diseases that plague our community.
May 12, 2010, 10:01 GMT
Phoenix - Today, CVS/pharmacy announces ExtraCare Advantage for Diabetes, a new program available to ExtraCare cardholders which provides savings and rewards on the purchase of over-the-counter diabetes-related products in addition to wellness education benefits.
May 12, 2010, 09:47 GMT
The drug otelixizumab appears to halt the rapid decline in the body's production of insulin, according to a recent study published in the journal 'Diabetologia'. This rapid decline of insulin production occurs in people with Type 1 diabetes due to an auto-immune response. The drug works by switching off the immune system's self-destruct mechanism that causes Type 1 diabetes. This halts damage to ...
May 12, 2010, 09:41 GMT
The complimentary Sanibel-Captiva Lions Club diabetes screening uses a tiny drop of blood extracted with an almost painless prick of the finger, which is then read by a blood glucose meter in 10 seconds.
May 12, 2010, 08:51 GMT
Roux-en-Y gastric bypass (RYGB) is a commonly used surgical treatment for patients with morbid obesity. It significantly and persistently decreases the levels of blood glucose and glycosylated hemoglobin in 80-100 percent of type 2 diabetes mellitus (T2DM) patients. A study group from China found the possible mechanism of treating T2DM with RYGB surgery. This study has provided new basis for ...
May 12, 2010, 08:18 GMT
A study to be published in the latest issue of The Cochrane Library and led by researchers at the University of Edinburgh and supported by colleagues at the Peninsula Dental School, the University of Ottawa and UCL Eastman Dental Institute, suggests that the treatment of serious gum (periodontal) disease in diabetics with Type 2 diabetes may lower their blood sugar levels. The research team ...
May 12, 2010, 07:55 GMT
Association Urges Significant Expansion of Federal Funding to Stop Diabetes
May 12, 2010, 07:06 GMT
It has so far not been proven that the long-acting insulin analogues (LAIAs) insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of type 1 diabetes, offer patients an additional benefit versus long-acting human insulin. This applies to adults as well as to children and adolescents. This is the result of the final report published ...
May 12, 2010, 06:50 GMT
It has so far not been proven that the long-acting insulin analogues insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of type 1 diabetes, offer patients an additional benefit versus long-acting human insulin. This is the conclusion of a report by the German Institute for Quality and Efficiency in Health Care which was published ...
May 12, 2010, 06:50 GMT
( Institute for Quality and Efficiency in Health Care ) It has so far not been proven that the long-acting insulin analogues insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of type 1 diabetes, offer patients an additional benefit versus long-acting human insulin. This is the conclusion of a report by the German Institute for ...
May 12, 2010, 06:33 GMT
( World Journal of Gastroenterology ) Roux-en-Y gastric bypass (RYGB) is a commonly used surgical treatment for patients with morbid obesity. It significantly and persistently decreases the levels of blood glucose and glycosylated hemoglobin in 80-100 percent of type 2 diabetes mellitus (T2DM) patients. A study group from China found the possible mechanism of treating T2DM with RYGB surgery ...
May 12, 2010, 06:27 GMT
COBOURG -- Cobourg council this week heard updates on the state of diabetes services in the community, part of John Hassan's update on the Port Hope Community Health Centre (PHCHC) in the year since he previously addressed council on the topic. Diabetes education is a field in which the PHCHC is [...]
May 12, 2010, 04:36 GMT
In the run-up to Diabetes Week and the Football World Cup, Diabetes UK has launched a keepy uppy competition to find the most unusual location that a person can do a series of keepy uppies. The competition is open to all and prizes include a signed football from the Guinness World Keepy Uppy Champion Dan Magness, a summer holiday kit and Toni and Guy hair products. Have some fun Dan Magness said ...
May 12, 2010, 04:36 GMT
Routine dental treatment can reduce blood glucose levels in people with type 2 diabetes who have preexisting gum disease. Researchers analyzed seven studies of people ages 16 and older with either type 1 or type 2 diabetes who had periodontitis, a bacteria-caused disease that attacks the gums, tissue and bone that support the teeth. After combining data for 244 patients from the three most ...
May 12, 2010, 02:53 GMT
THE family of a York teenager who died after developing diabetes have decided to take part in the Great North Run to help other victims of the illness.
May 12, 2010, 02:47 GMT
A study to be published in the latest issue of The Cochrane Library and led by researchers at the University of Edinburgh and supported by colleagues at the Peninsula Dental School, the University of Ottawa and UCL Eastman Dental Institute, suggests that the treatment of serious gum (periodontal) disease in diabetics with Type 2 diabetes may lower their blood sugar levels.
|
|